UK Apheresis Equipment Market Size & Outlook, 2023-2030
UK apheresis equipment market, 2018-2030 (US$M)
Related Markets
UK apheresis equipment market highlights
- The UK apheresis equipment market generated a revenue of USD 171.9 million in 2023 and is expected to reach USD 343.3 million by 2030.
- The UK market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, disposable apheresis kits was the largest revenue generating product in 2023.
- Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Apheresis equipment market data book summary
| Market revenue in 2023 | USD 171.9 million |
| Market revenue in 2030 | USD 343.3 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Disposable apheresis kits |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable Apheresis Kits, Devices |
| Key market players worldwide | Asahi Kasei Corp, Terumo Corp, Fresenius SE & Co KGaA, Haemonetics Corp, B. Braun, Nikkiso Co Ltd, Mallinckrodt PLC Ordinary Shares - New |
Other key industry trends
- In terms of revenue, UK accounted for 5.9% of the global apheresis equipment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany apheresis equipment market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 343.3 million by 2030.
Disposable apheresis kits was the largest segment with a revenue share of 72.43% in 2023. Horizon Databook has segmented the UK apheresis equipment market based on disposable apheresis kits, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The UK apheresis equipment market includes prominent players such as B. Braun Melsungen AG; Haemonetics Corporation; Fresenius Kabi AG; Asahi Kasei Medical Co., Ltd.; Terumo BCT, Inc.; Mallinckrodt; and Nikkiso Europe GmbH, holding significant market share. These companies employ diverse strategies to expand their market presence.
For instance, in July 2020, Mallinckrodt and Terumo BCT received positive recommendations in Australia for public funding of UVADEX with the THERAKOS CELLEX Photopheresis System for treating Cutaneous T-cell Lymphoma (CTCL) in adults, based on clinical and cost-effectiveness evaluations. The positive recommendations show a growing acceptance and adoption of therapeutic apheresis procedures for treating cutaneous T-cell lymphoma.
This could potentially drive demand for apheresis equipment, particularly systems compatible with photo pheresis treatments, in the global market. In addition, in June 2023, Mallinckrodt plc published findings from a European study on Extracorporeal Photopheresis (ECP) in heart transplant patients, highlighting its real-world use and impact on graft rejection prevention & treatment.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Apheresis Equipment Market Scope
Apheresis Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK apheresis equipment market size, by product, 2018-2030 (US$M)
UK Apheresis Equipment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
